Related Experiment Video

Updated: Jul 7, 2026

Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
09:56

Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins

Published on: October 31, 2025

Epigenome-derived drugs: recent advances and future perspectives

Paraskevi Vogiatzi1, Pierpaolo Aimola, Maria Irene Scarano

  • 1Department of Molecular Biology, Medical Genetics Unit, University of Siena, Siena, Italy.

Drug News & Perspectives
|February 28, 2008
PubMed

Insights

This review explores epigenetic targets for cancer therapy, noting current limitations and challenges in prevention. Promising strategies include enhancing treatment sensitivity and combining epigenetic drugs with other therapies.

Area of Science:

  • Oncology
  • Epigenetics
  • Pharmacology

Background:

  • Epigenetic modifications play a crucial role in cancer development and progression.
  • Epigenetic therapies aim to reverse aberrant epigenetic changes for cancer treatment.
  • Current knowledge on epigenetic targets for anticancer therapy is rapidly evolving.

Purpose of the Study:

  • To review current knowledge of epigenetic targets in anticancer therapy.
  • To outline limitations of existing epigenetic approaches.
  • To discuss promising strategies for developing effective epigenetic treatments.

Main Methods:

  • Literature review of current research on epigenetic targets and therapies.
  • Analysis of challenges in defining preventive epigenetic tools and strategies.
  • Discussion of novel therapeutic strategies and combinations.

Main Results:

  • Epigenetic therapies offer a promising avenue for cancer treatment.
  • Significant limitations exist in current epigenetic approaches, including challenges in prevention.
  • Restoration of sensitivity to other treatments and combination therapies show promise.

Conclusions:

  • Epigenetic therapies are a vital area of cancer research with potential for significant impact.
  • Overcoming current limitations requires innovative strategies and further research.
  • Combination therapies and exploration of new therapeutic areas are key to advancing epigenetic anticancer treatments.

More Related Videos

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.